Dáil Éireann Debate, Tuesday - 26 May 2026
1099. Deputy Pádraig O'Sullivan asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy; and if she will make a statement on the matter. [38709/26]
View answerI propose to take PQs 38755/26, 38709/26 and 38707/26, together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
